文献速递泌尿生殖腹部MR

透明细胞可能性评分可能改善肾脏肿块的诊断与管理

Clear cell likelihood score may improve diagnosis and management of renal masses.
PubMed 文献 · Abdom Radiol (NY) · 2024-06-20

本文综述肾脏实性肿块的影像学评估,指出约20%小于4cm的病灶为良性、80%为恶性,ccRCC占肾癌的65-80%。透明细胞可能性评分(ccLS)是一种新型MRI工具,用于评估肾脏肿块为ccRCC的概率,以促进泌尿外科医生与患者共同决策。

要点

  • ccLS是一种MRI工具,用于评估肾脏肿块为ccRCC的概率。
  • 约20%小于4cm的肾脏实性肿块为良性,80%为恶性。
  • ccRCC占肾癌的65-80%,是肾癌中最常见的类型。

核心结论

  • ccLS作为一种新型MRI工具,可评估肾脏肿块为ccRCC的概率,有助于促进泌尿外科医生与患者之间的共同决策。

研究设计与样本

  • 本文为综述,回顾肾脏肿块的评估及ccLS的应用,未报告系统检索范围与纳入文献数量。

临床应用与阅片要点

  • 主动监测是诊断为肾脏实性肿块患者的一种保守管理方法,得到美国泌尿外科协会和欧洲肿瘤内科学会的认可;但主动监测仅用于少数患者,且各机构间存在差异;缺乏采用标准化方法研究偶然发现的小肾脏肿块的临床研究,妨碍了主动监测的广泛使用;需要更好的患者选择,以区分需要手术的患者和适合主动监测的患者。

局限性

  • 缺乏采用标准化方法研究偶然发现的小肾脏肿块的临床研究,妨碍了主动监测的广泛使用。
  • 主动监测仅用于少数患者,且各机构间存在差异。
  • 目前只有组织学分析才能提供准确诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The detection of solid renal masses has increased over time due to incidental findings during imaging studies conducted for unrelated medical conditions. Approximately 20% of lesions measuring less than 4 cm are benign and 80% are malignant. Clear cell renal cell carcinoma (ccRCC) is the most frequent among renal carcinomas, responsible for 65-80% of cases. The increased detection of renal masses facilitates early diagnosis and treatment. However, it also leads to more invasive interventions, which result in higher morbidity and costs. Currently, only histological analysis can offer an accurate diagnosis. Surgical nephron loss significantly elevates morbidity and mortality rates. Active surveillance represents a conservative management approach for patients diagnosed with a solid renal mass that is endorsed by both American Urological Association and the European Society for Medical Oncology. However, active surveillance is used in a minority of patients and varies across institutions. The lack of clinical studies using a standardized approach to incidentally detected small renal masses precludes the widespread use of active surveillance. Hence, there is an urgent need for better patient selection, distinguishing those who require surgery from those suitable for active surveillance. The clear cell likelihood score (ccLS) represents a novel MRI tool for assessing the probability of a renal mass being a ccRCC. In this study, we present a comprehensive review of renal masses and their evaluation using the ccLS to facilitate shared decision between urologists and patients.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Salles-Silva E, Lima EM, Amorim VB, et al. Clear cell likelihood score may improve diagnosis and management of renal masses. Abdom Radiol (NY). 2024. PMID: 38900323. doi:10.1007/s00261-024-04415-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。